Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

News flash for biopharma bosses: More than half your employees want to leave
Fierce Pharma
Tuesday, July 22, 2014 - 6:04pm
tags:
pharma employees
Puma Biotechnology shares more than triple on postive trial data
Marketwatch
Tuesday, July 22, 2014 - 6:03pm
tags:
Puma Biotechnology, breast cancer, neratinib
Intuitive Surgical Soars on Large Earnings Surprise
Motley Fool
Tuesday, July 22, 2014 - 6:01pm
tags:
Intuitive Surgical, devices, earnings
Allergan Reiterates Plan to Preempt Valeant Offer
TheStreet.com
Tuesday, July 22, 2014 - 5:13pm
tags:
Allergan, Valeant Pharmaceuticals, M&A
Bayer/Regeneron Continue to Progress with Eylea
Yahoo/Zacks.com
Tuesday, July 22, 2014 - 5:12pm
tags:
Bayer, Regeneron, Eylea, diabetic macular edema
3 Quotes From Johnson & Johnson's Conference Call You Need to Read
Motley Fool
Tuesday, July 22, 2014 - 5:11pm
tags:
JNJ, Olysio, earnings, biosimilars
Could This 1 Lawsuit Destroy Biogen Idec Stock?
Motley Fool
Tuesday, July 22, 2014 - 5:08pm
tags:
BiogenIdec, Tecfidera, MS, multiple sclerosis, patents, Actavis, Mylan, Synthon Pharmaceuticals, Novartis, Hexal, Sanofi, Zentiva
Galena Gives Sales Team Another Useless Product to Promote
TheStreet.com
Tuesday, July 22, 2014 - 12:01pm
tags:
Galena Biopharma, MonoSol Rx, Zuplenz, chemotherapy-induced nausea and vomiting
Hemispherx achieves high ranking in sensitivity testing against MERS/SARS
Yahoo/Fly on the Wall
Tuesday, July 22, 2014 - 11:59am
tags:
Hemispherx, MERS virus, SARS
Do This Drug's Sales Make J&J a Hepatitis C Powerhouse?
Motley Fool
Tuesday, July 22, 2014 - 11:49am
tags:
JNJ, hepatitis C, Olysio
Here's What You Need to Know About AbbVie and GlaxoSmithKline's Upcoming Earnings
Motley Fool
Tuesday, July 22, 2014 - 11:45am
tags:
AbbVie, GSK, earnings
Roche CEO: No appetite for expensive megadeals here
Fierce Pharma
Tuesday, July 22, 2014 - 9:54am
tags:
Pharma CEOs, Roche, Severin Schwan, M&A
JAMA: Hep C drugs could add $300 to every American's insurance premium
Fierce Pharma
Tuesday, July 22, 2014 - 9:51am
tags:
insurance, hepatitis C, Sovaldi
Allergan stand alone value now above Valeant offer, says Bernstein
The Fly on the Wall
Tuesday, July 22, 2014 - 9:00am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Actelion Raises Full-Year Profit Forecast on Opsumit
Bloomberg
Tuesday, July 22, 2014 - 8:58am
tags:
Actelion, Opsumit, Tracleer, earnings
Thermo Fisher Wins 3 Oscars of Innovation, Shares Rise
Yahoo/Zacks.com
Tuesday, July 22, 2014 - 8:56am
tags:
Thermo Fisher
Alkermes' Pipeline Development Impresses, Key Updates Ahead
Yahoo/Reuters
Tuesday, July 22, 2014 - 8:54am
tags:
Alkermes, Invega Sustenna, ALKS 3831, aripiprazole lauroxil, ALKS 5461
Celgene drug can drive HIV out of hiding -study
Yahoo/Reuters
Tuesday, July 22, 2014 - 8:50am
tags:
HIV, Celgene, romidepsin, AIDS
Kindred says prepared to raise offer for Gentiva
Yahoo/Reuters
Tuesday, July 22, 2014 - 8:48am
tags:
Kindred Healthcare, Gentiva Health Services, M&A
Drugmakers to share neglected compounds with British academia
Yahoo/Reuters
Tuesday, July 22, 2014 - 8:47am
tags:
UK, R&D, AstraZeneca, GSK, JNJ, Eli Lilly, Pfizer, Takeda, UCB Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.